News|Videos|June 11, 2024

The Impact of Widespread RSV Vaccination and Quantifying Results

In the fourth and final episode, the clinicians speak of the need for greater uptake of the RSV vaccines, overcoming an "RSV identity crisis," and the potential ancillary benefit of reducing bacterial infections.

There are now 3 FDA-approved RSV vaccines for seniors. Throughout this series we have looked at the efficacy, safety, and mechanism of action of the immunizations. Now it is time to look at the big picture perspective and identify what RSV vaccination means on a larger scale.

In our new short series titled, Special Report: Clinical Insights on Moderna's RSV Vaccine, Ann Falsey, MD, professor of Medicine at the University Of Rochester School Of Medicine, and Edward Walsh, MD, also a professor of Medicine at the University Of Rochester School Of Medicine
have a peer-to-peer discussion on the impact these vaccines may have in preventing this respiratory illness.

In this fourth and final episode, Falsey and Walsh discuss what it will take to measure the impact of these vaccines and some of the other important takeaways regarding these newer prophylactic modalities.


Related to this article

Asymptomatic C difficile Colonization in Infants Doesn’t Mean Benign
A new study in infants challenges the long-standing belief about the pathogen’s effects in the youngest pediatric population. Senior author Joseph Zackular, PhD, provides insights around his work including how it reshapes gut development and offers potential intervention strategies to shield neonates.
How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.